Skip To Main Content
Ballman KV on Muck Rack

Ballman KV

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ballman

Contact Ballman, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

ROMA:Women - a trial dedicated to women to improve coronary bypass outcomes

|
By Bairey Merz CN, Ballman KV, O'Brien SM, Creber RM
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (630) Issue with article?

Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance)

|
By Boughey JC, Rosenkranz KM, Ballman KV, Haffty BG
| ncbi.nlm.nih.gov
Abstract Purpose: Breast-conserving therapy (BCT) is the preferred treatment for unifocal breast cancer (BC). The oncologic safety of BCT for multiple ipsilateral breast cancer (MIBC) has not been demonstrated in a prospective study. ACOSOG Z11102 (Alliance) is a phase II, single-arm, prospective trial designed to evaluate oncologic outcomes in patients undergoing BCT for MIBC. Patients and methods: Women age 40 years and older with two to three foci of biopsy-proven cN0-1 BC were eligible.
Open in Who Shared Issue with article?
See all 2 articles